Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wu, Jia
GOT, NCT05557578: Applied as Neoadjuvant Regimen for Patients of Resectable ICC With High-risk Factors of Recurrence	Recruiting	2	20	RoW	Tislelizumab combined with GEMOX (GOT) regimen, Gemcitabine, Oxaliplatin	Zhejiang Cancer Hospital	Intrahepatic Cholangiocarcinoma	10/24	12/24
HAICI, NCT06741020: Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma	Not yet recruiting	1/2	10	RoW	Adebrelimab, Oxaliplatin, Fluorouracil,Leucovorin	Zhejiang Cancer Hospital	Hepatocellular Carcinoma (HCC)	06/26	12/26
NCT04859153: Relevant Factors on Sprint Performance in Adolescent Sprinters	Completed	N/A	30	RoW	central nerve sensory, motor control and various muscle mechanical characteristic and sport-related fitness test	China Medical University Hospital	Sprint Performance, Physical Fitness, Muscle Architecture, Reaction Time	02/22	02/22
Hsieh, Yueh - Ling
NCT04859153: Relevant Factors on Sprint Performance in Adolescent Sprinters	Completed	N/A	30	RoW	central nerve sensory, motor control and various muscle mechanical characteristic and sport-related fitness test	China Medical University Hospital	Sprint Performance, Physical Fitness, Muscle Architecture, Reaction Time	02/22	02/22